FDA Moves to Reevaluate Several Peptides American Med Spa Association In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B What are the risks and benefits of using BPC 157 (Body Protection Compound 157) peptide for medical treatment?